Letting Children be Children
Hear from this Paediatric team at Freeman Hospital, Newcastle, UK
While the advantages of early mobility in critical care are widely acknowledged[1] , its profound impact on patient mental well-being is equally significant. Hear from this Paediatric team at Freeman Hospital, Newcastle, UK, as they share their experience on how much Vapotherm’s mobility solution positively impacts their patients and their families.
The ability of young patients to move and engage in physical activity plays a crucial role in achieving positive clinical results. HVT 2.0 allows you to seamlessly maintain therapy while children play, walk, or during transfer – wherever and whenever it’s required within the hospital setting!
Described by these clinicians as a “game-changing” experience, discover Vapotherm technology for providing respiratory therapy on the go!
Register for our upcoming Late Night Webinar
Tuesday, July 16th at 10:00 pm EST - Register Here!
Join three of the Principal Investigators of HYPERACT, the 2024 Society of Critical Care Medicine Star Research Award Winner, which determined High Velocity Therapy as a reasonable alternative to NiPPV for moderate - severely hypercapnic, COPD patients (for spontaneously breathing patients only).